ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Qingbo Meng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-5440-9463; OpenAlex author ID A5103113719. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 2 papers

Papers 2

Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.xcrm.2024.101731 ↗
ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion. Co-author DOI 10.1038/s41420-024-01862-2 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lihong He · 2 shared papers, 2024 · strength 0.41
- Paper ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism repro… DOI 10.1038/s41420-024-01862-2 ↗
- Paper Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma. DOI 10.1016/j.xcrm.2024.101731 ↗
Kang Sun · 2 shared papers, 2024 · strength 0.41
- Paper ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism repro… DOI 10.1038/s41420-024-01862-2 ↗
- Paper Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma. DOI 10.1016/j.xcrm.2024.101731 ↗
Tingbo Liang · 1 shared paper, 2024 · strength 0.24
- Paper ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism repro… DOI 10.1038/s41420-024-01862-2 ↗
Hanshen Yang · 1 shared paper, 2024 · strength 0.17
- Paper Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma. DOI 10.1016/j.xcrm.2024.101731 ↗
Tingbo Liang · 1 shared paper, 2024 · strength 0.17
- Paper Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma. DOI 10.1016/j.xcrm.2024.101731 ↗
Xueli Bai · 1 shared paper, 2024 · strength 0.17
- Paper Reprograming immunosuppressive microenvironment by eIF4G1 targeting to eradicate pancreatic ductal adenocarcinoma. DOI 10.1016/j.xcrm.2024.101731 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.